Durham, NC, United States of America

Ibtehaj Naqvi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Duke University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ibtehaj Naqvi. Retrieved from https://idiyas.com/inventor/ibtehaj-naqvi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Ibtehaj Naqvi

Introduction

Ibtehaj Naqvi is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of polycationic polymers. His work focuses on methods that enhance the detection and treatment of cancer, showcasing his commitment to advancing medical science.

Latest Patents

Ibtehaj Naqvi holds a patent for "Polycationic polymers for use in treating and detecting cancer." This patent outlines methods of treating cancer in a subject by administering a therapeutically effective amount of a polycationic polymer. Additionally, it describes methods for detecting cancer or metastasis by analyzing bodily fluids for circulating free DNA (cfDNA), cfRNA, inorganic polyphosphates, or the number of exosomes or nucleosomes present in the sample. This innovative approach has the potential to significantly improve cancer diagnosis and treatment.

Career Highlights

Naqvi is affiliated with Duke University, where he continues to engage in groundbreaking research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic strategies in oncology. His dedication to research and innovation is evident in his patent and ongoing projects.

Collaborations

Some of his notable coworkers include Bruce A Sullenger and Ruwan Gunaratne. Their collaborative efforts contribute to the advancement of cancer research and the development of effective treatment methodologies.

Conclusion

Ibtehaj Naqvi's contributions to cancer treatment through his innovative patent demonstrate his expertise and commitment to improving patient outcomes. His work at Duke University continues to inspire advancements in medical research and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…